Renhe Pharmacy Co Ltd (000650)

Shenzhen
Currency in CNY
5.50
-0.01(-0.18%)
Closed·
000650 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
000650 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.495.52
52 wk Range
5.107.03
Key Statistics
Edit
Bid/Ask
5.50 / 5.50
Prev. Close
5.51
Open
5.51
Day's Range
5.49-5.52
52 wk Range
5.1-7.03
Volume
16.67M
Average Volume (3m)
14.4M
1-Year Change
-4.17%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000650 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Renhe Pharmacy Co Ltd Company Profile

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.

Employees
5394
Market
China

Compare 000650 to Peers and Sector

Metrics to compare
000650
Peers
Sector
Relationship
P/E Ratio
16.3x27.7x−0.5x
PEG Ratio
−1.00−0.560.00
Price/Book
1.2x2.4x2.6x
Price / LTM Sales
2.0x3.2x3.1x
Upside (Analyst Target)
-17.9%47.8%
Fair Value Upside
Unlock4.2%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.34%
Dividend Yield
2.72%
Industry Median 1.58%
Annualised payout
0.15
Paid annually
5-Years Growth
+8.45%
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.12 / --
Revenue / Forecast
985.65M / --
EPS Revisions
Last 90 days

000650 Income Statement

FAQ

What Stock Exchange Does Renhe Pharm A Trade On?

Renhe Pharm A is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Renhe Pharm A?

The stock symbol for Renhe Pharm A is "000650."

What Is the Renhe Pharm A Market Cap?

As of today, Renhe Pharm A market cap is 7.61B.

What Is Renhe Pharm A's Earnings Per Share (TTM)?

The Renhe Pharm A EPS (TTM) is 0.34.

From a Technical Analysis Perspective, Is 000650 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Renhe Pharm A Stock Split?

Renhe Pharm A has split 7 times.

How Many Employees Does Renhe Pharm A Have?

Renhe Pharm A has 5394 employees.

What is the current trading status of Renhe Pharm A (000650)?

As of 09 Jul 2025, Renhe Pharm A (000650) is trading at a price of 5.50, with a previous close of 5.51. The stock has fluctuated within a day range of 5.49 to 5.52, while its 52-week range spans from 5.10 to 7.03.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.